Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000878088-10-000027)

Filing Details

Accession Number:: 0000878088-10-000027
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2010-03-24 13:00:00
Reporting Period:: 2010-03-09

Filing Date:: 2010-03-24
Accepted Time:: 2010-03-24 12:38:04
Original Submission Date:: 2010-03-10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
878088	Par Pharmaceutical Companies Inc.	PRX	Pharmaceutical Preparations (2834)	223122182

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1339976	A John Macphee	C/O Par Pharmaceutical Companies, Inc. 300 Tice Boulevard Woodcliff Lake NJ 07677	Evp, Pres-Strativa	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-09	3,229	$25.03	120,764	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is being filed to correct a typographical error. This entry was incorrectly reported as 3,299 shares sold; the correct number of shares sold was 3,229. The total number of shares beneficially owned following the transaction was correctly reported as 120,764, which includes (i) 17,020 shares of Common Stock, and (ii) 103,744 shares of Restricted Stock and Restricted Stock Units, held by Mr. MacPhee.